The Cooper Companies, Inc. (NASDAQ:COO) Stock Position Decreased by National Pension Service

National Pension Service cut its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 8.6% in the fourth quarter, Holdings Channel reports. The firm owned 298,860 shares of the medical device company’s stock after selling 28,200 shares during the period. National Pension Service’s holdings in Cooper Companies were worth $27,474,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Ashton Thomas Securities LLC purchased a new stake in shares of Cooper Companies during the 3rd quarter worth about $25,000. Covestor Ltd raised its stake in shares of Cooper Companies by 144.9% during the 3rd quarter. Covestor Ltd now owns 338 shares of the medical device company’s stock worth $37,000 after purchasing an additional 200 shares in the last quarter. Byrne Asset Management LLC purchased a new stake in shares of Cooper Companies during the 4th quarter worth about $33,000. Brown Brothers Harriman & Co. raised its stake in shares of Cooper Companies by 191.0% during the 3rd quarter. Brown Brothers Harriman & Co. now owns 419 shares of the medical device company’s stock worth $46,000 after purchasing an additional 275 shares in the last quarter. Finally, West Financial Advisors LLC purchased a new stake in shares of Cooper Companies during the 4th quarter worth about $49,000. 24.39% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

COO has been the subject of a number of recent research reports. StockNews.com downgraded Cooper Companies from a “buy” rating to a “hold” rating in a research note on Wednesday, December 11th. Morgan Stanley cut their price objective on Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating on the stock in a research note on Friday, December 6th. Needham & Company LLC reissued a “hold” rating on shares of Cooper Companies in a research note on Friday, December 6th. Citigroup cut their price objective on Cooper Companies from $116.00 to $115.00 and set a “buy” rating on the stock in a research note on Friday, December 6th. Finally, Wells Fargo & Company raised their price objective on Cooper Companies from $115.00 to $118.00 and gave the company an “overweight” rating in a research note on Friday, December 6th. Three analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Cooper Companies presently has an average rating of “Moderate Buy” and a consensus price target of $117.22.

Cooper Companies Stock Performance

COO opened at $90.38 on Friday. The firm has a market capitalization of $18.04 billion, a P/E ratio of 46.35, a price-to-earnings-growth ratio of 2.25 and a beta of 1.00. The stock’s 50 day moving average price is $92.64 and its two-hundred day moving average price is $99.53. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32. The Cooper Companies, Inc. has a 12-month low of $84.76 and a 12-month high of $112.38.

Cooper Companies (NASDAQ:COO) last released its earnings results on Thursday, December 5th. The medical device company reported $1.04 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.00 by $0.04. The firm had revenue of $1.02 billion for the quarter, compared to analyst estimates of $1.03 billion. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The company’s revenue was up 9.8% on a year-over-year basis. During the same quarter last year, the firm posted $0.87 EPS. On average, equities analysts forecast that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.